S'abonner

Summary of the Keystone Symposium “Origins of allergic disease: Microbial, epithelial and immune interactions,” March 24-27, Tahoe City, California - 06/04/20

Doi : 10.1016/j.jaci.2019.11.048 
Rosemarie H. DeKruyff, PhD a, b, , Wenming Zhang, PhD a, b, Kari C. Nadeau, MD, PhD a, b, Donald Y.M. Leung, MD, PhD c, Marsha Wills-Karp, PhD d
a Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University, Stanford, Calif 
b Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif 
c Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, National Jewish Health, Denver, Colo 
d Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md 

Corresponding author: Rosemarie H. DeKruyff, PhD, Department of Medicine, Stanford University, Stanford, CA 94305.Department of MedicineStanford UniversityStanfordCA94305

Abstract

The aims of the Keystone Symposium conference, “Origins of allergic disease: Microbial, epithelial and immune interactions” were to present and discuss potential microbial-epithelial-immune interactions underlying the early-life origins of allergic disorders, as well as immune mechanisms that might suggest novel disease prevention or intervention strategies. Cross-talk and sharing of ideas among participating experts in basic science and clinical aspects of allergic diseases provided substantial insight into the concept of allergic disorders as a systems disease. The overriding message distilled from the discussions was that damage to epithelial surfaces lies at the origin of the various manifestations of allergic disease. The epithelium of the lungs, gut, and skin, which operates as a critical sensor of environmental stimuli, is besieged by an onslaught of contemporary environmental forces including an altered microbiome, air pollution, food allergens in a changed diet, and chemicals in modern detergents. Collectively, this onslaught leads to alterations of lung, skin, or gut epithelial surfaces, driving a type 2 immune response that underlies most, if not all, of the atopic diseases. Possible remedies for treatment and prevention of allergic diseases were discussed, including a precision medicine approach using biologics, oral desensitization, targeted gut microbiome alterations, and behavior alteration.

Le texte complet de cet article est disponible en PDF.

Key words : Atopic dermatitis, food allergy, asthma, microbiome, epithelial barrier

Abbreviations used : AD, CC16, CMA, DC, EoE, FA, FLG, LoF, NPM, RV, TSLP


Plan


 This work was supported by the Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, California (R.H.D., W.Z., and K.C.N.). D.Y.M.L. is supported by National Institutes of Health grants 1U19AI117673, 5R01AR41256, UL1TR002535, 1UM2AI130836, and UM1AI130780.
 Disclosure of potential conflict of interest: K. C. Nadeau reports grants from the National Institute of Allergy and Infectious Diseases (NIAID), Food Allergy Research & Education (FARE), End Allergies Together, Allergenis, and Ukko Pharma; is grant awardee at NIAID, National Institute of Environmental Health Sciences, National Heart, Lung, and Blood Institute (NHLBI), and the Environmental Protection Agency; is involved in clinical trials with Regeneron, Genentech, AImmune Therapeutics, DBV Technologies, AnaptysBio, Adare Pharmaceuticals, and Stallergenes Greer; received research sponsorship by Novartis, Sanofi, Astellas, and Nestle; is Data and Safety Monitoring Board member at Novartis and NHLBI; cofounded BeforeBrands, Alladapt, ForTra, and Iggenix; is Director of FARE and World Allergy Organization (WAO) Center of Excellence; and received personal fees from Regeneron, Astrazeneca, ImmuneWorks, and Cour Pharmaceuticals. The rest of the authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 145 - N° 4

P. 1072 - avril 2020 Retour au numéro
Article précédent Article précédent
  • On the cause and consequences of IgE to galactose-?-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy
  • Thomas A.E. Platts-Mills, Scott P. Commins, Tilo Biedermann, Marianne van Hage, Michael Levin, Lisa A. Beck, Maria Diuk-Wasser, Uta Jappe, Danijela Apostolovic, Michael Minnicozzi, Marshall Plaut, Jeffrey M. Wilson
| Article suivant Article suivant
  • Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
  • Marcus S. Shaker, Dana V. Wallace, David B.K. Golden, John Oppenheimer, Jonathan A. Bernstein, Ronna L. Campbell, Chitra Dinakar, Anne Ellis, Matthew Greenhawt, David A. Khan, David M. Lang, Eddy S. Lang, Jay A. Lieberman, Jay Portnoy, Matthew A. Rank, David R. Stukus, Julie Wang, Collaborators, Natalie Riblet, Aiyana M.P. Bobrownicki, Teresa Bontrager, Jarrod Dusin, Jennifer Foley, Becky Frederick, Eyitemi Fregene, Sage Hellerstedt, Ferdaus Hassan, Kori Hess, Caroline Horner, Kelly Huntington, Poojita Kasireddy, David Keeler, Bertha Kim, Phil Lieberman, Erin Lindhorst, Fiona McEnany, Jennifer Milbank, Helen Murphy, Oriana Pando, Ami K. Patel, Nicole Ratliff, Robert Rhodes, Kim Robertson, Hope Scott, Audrey Snell, Rhonda Sullivan, Varahi Trivedi, Azadeh Wickham, Chief Editors, Marcus S. Shaker, Dana V. Wallace, Workgroup Contributors, Marcus S. Shaker, Dana V. Wallace, Jonathan A. Bernstein, Ronna L. Campbell, Chitra Dinakar, Anne Ellis, David B.K. Golden, Matthew Greenhawt, Jay A. Lieberman, Matthew A. Rank, David R. Stukus, Julie Wang, Joint Task Force on Practice Parameters Reviewers, Marcus S. Shaker, Dana V. Wallace, David B.K. Golden, Jonathan A. Bernstein, Chitra Dinakar, Anne Ellis, Matthew Greenhawt, Caroline Horner, David A. Khan, Jay A. Lieberman, John Oppenheimer, Matthew A. Rank, Marcus S. Shaker, David R. Stukus, Julie Wang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.